Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/8402
TYPE 1 AND TYPE 2 RESPONSES TO LEISHMANIA MAJOR
Leishmaniose Cutânea/imunologia
Células Th1/imunologia
Animais
Apresentação do Antígeno
Antígenos CD/imunologia
Suscetibilidade a Doenças
Previsões
Humanos
Proteínas de Insetos/imunologia
Insetos Vetores/parasitologia
Leishmaniose Cutânea/transmissão
Ativação Linfocitária
Camundongos
Camundongos Endogâmicos
Vacinas Protozoárias/imunologia
Psychodidae/imunologia
Saliva/parasitologia
Proteínas e Peptídeos Salivares/imunologia
Células Th1/secreção
Author
Affilliation
University of Northern Colorado. Department of Biological Sciences. Greeley, Colorado
University of Northern Colorado. Department of Biological Sciences. Greeley, Colorado
Biopharmaceutical Research, Centocor. Malvern, PA, USA
Colorado State University. College of Veterinary Medicine and Biomedical Sciences. Department of Microbiology, Immunology and Pathology. CO, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
University of Northern Colorado. Department of Biological Sciences. Greeley, Colorado
University of Northern Colorado. Department of Biological Sciences. Greeley, Colorado
Biopharmaceutical Research, Centocor. Malvern, PA, USA
Colorado State University. College of Veterinary Medicine and Biomedical Sciences. Department of Microbiology, Immunology and Pathology. CO, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil
University of Northern Colorado. Department of Biological Sciences. Greeley, Colorado
Abstract
Leishmania major is a protozoan parasite that is transmitted to the mammalian host by its sand fly vector when the fly probes in the
host's skin for a blood meal and injects the parasite within its saliva. In mice experimentally infected with L. major, outgrowth of CD4
type 1 (Th1) cells leads to resolution of the infection, but outgrowth of type 2 (Th2) cells exacerbates disease. To design an effective
vaccine against the parasite (and other pathogens that induce polarized Th1 and Th2 responses), we must determine the mechanism
underlying this phenomenon so that we can design the vaccine to elicit the appropriate (i.e., protective) Th cell. Recent work indicates that
Th bias is influenced by a number of signals delivered by antigen-presenting cells, including cytokines and co-stimulatory molecules.
Moreover, recent work also suggests that sand fly saliva influences the immune response to L. major and Th polarization. Determining the
mechanisms that lead to polarized Th responses should expand our knowledge regarding immunity to L. major, and should add to our
understanding of immunoregulation in general
DeCS
Leishmania major/imunologiaLeishmaniose Cutânea/imunologia
Células Th1/imunologia
Animais
Apresentação do Antígeno
Antígenos CD/imunologia
Suscetibilidade a Doenças
Previsões
Humanos
Proteínas de Insetos/imunologia
Insetos Vetores/parasitologia
Leishmaniose Cutânea/transmissão
Ativação Linfocitária
Camundongos
Camundongos Endogâmicos
Vacinas Protozoárias/imunologia
Psychodidae/imunologia
Saliva/parasitologia
Proteínas e Peptídeos Salivares/imunologia
Células Th1/secreção
Share